key: cord-0767882-zxdtk1jg
authors: Min, Jinjin; Qin, Qiyu; Jin, Xiuming
title: Re: Yu et al.: Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019(COVID-19) Patients
date: 2020-05-25
journal: Ophthalmology
DOI: 10.1016/j.ophtha.2020.05.040
sha: 39c34ce534c297acaa52d753827a56380a7261e9
doc_id: 767882
cord_uid: zxdtk1jg

nan

To the Editor:

We would like to congratulate Yu et al. [1] for the well-written article that evaluated 64 tear samples from 17 COVID-19 patients and found that all tear samples tested negative for SARS-CoV-2, even for the one patient with ocular symptoms. They obtained a meaningful conclusion that the risk of ocular transmission of COVID-19 is low.

We applaud the authors for a major endeavor. However, we have different views on the role the ocular surface plays in COVID-19 transmission. Several potential limitations are worth discussing. First, the authors used a Schirmer's strip to collect tears, which may not be reliable enough to test SARS-CoV-2. Although the Schirmer's strip was previously validated in testing HSV-1 from tears [2] , no evidence shows it also works for SARS-CoV-2. In recent studies in China [3] Finally, even if the Schirmer's strip and RT-PCR tests were highly accurate, it still cannot be concluded that transmission through tears is likely to be low. We think that two possible explanations can account for this. One is that the COVID-19 infection above the ocular surface may not express SARS-CoV-2 in the tears, or the concentration of SARS-CoV-2 may be low. The other is that the authors may have missed the window, as the viral shedding in ocular tissue may only last for a short period. The authors did not mention the exact time of testing. Xia et al. [3] detected positive conjunctival swab samples at three days after the course of the disease, when the patient had no severe fever or respiratory symptoms. Due to these limitations, the negative results must be interpreted with caution.

In all, we believe that negative results do not conclusively show that the risk of ocular transmission for COVID-19 is low and even positive results can not be understood as the risk is high. Until now, the issue has been controversial, but we suggest that the conjunctiva is another transmission route for COVID-19. In Deng's study (Deng et al., 2020 PREPRINT, available from https://doi.org/10.1101/2020.03.13.990036), two rhesus macaques received 1×10 6 50% tissue-culture infectious doses (TCID 50 ) of SARS-CoV-2 conjunctival inoculation, and the results showed the viral load was distributed in the whole body at seven days after inoculation. However, this is a preprint article, and direct evidence for this conjecture is lacking. Nevertheless, we suggest that appropriate precautions are needed to prevent transmission through ocular tissues and secretions, especially for clinical staff. We hope that convincing

Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients

Comparative analysis of polymerase chain reaction assay for herpes simplex virus 1 detection in tear

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

The evidence of SARS-CoV-2 infection on ocular surface